Aim To investigate the diffusion of counterfeit medicines in developing countries and to verify the stability of galenic dosage forms to determine the stability of galenics prepared and stored in developing countries. Methods We purchased 221 pharmaceutical samples belonging to different therapeutic classes both in authorized and illegal pharmacies and subjected them to European Pharmacopoeia, 7th ed. quality tests. An ultraviolet-visible spectrophotometric assay was used to determine the galenics stability under different conditions of temperature (T) and relative humidity (RH). Results Substantial percentage of samples was substandard (52%) and thus had to be considered as counterfeit. Regarding the stability tests for galenics, it was possible to determine that the tested dosage forms were stable for a period of 24 months in “standard” (T=25±2°C, RH=50±5%) conditions. In “accelerated” (T=40±2°C, RH=50±5%) conditions, samples were stable for 3 months provided that they were stored in glass containers. Stability results of samples stored in “accelerated” conditions were similar to those obtained by performing tests on site in tropical countries and could so supply precious information on the expected stability of galenics in tropical countries. Conclusion This study gives useful information about the presence of counterfeit medicinal products in the pharmacies of many developing countries. This should serve as an alarm bell and an input for the production of galenics. We recommend setting up of galenic laboratories in developing countries around the globe.
Diffusion of counterfeit drugs in developing countries and stability of galenics stored for months under different conditions of temperature and relative humidity
BARATTA, Francesca;GERMANO, ANTONIO;BRUSA, Paola
2012-01-01
Abstract
Aim To investigate the diffusion of counterfeit medicines in developing countries and to verify the stability of galenic dosage forms to determine the stability of galenics prepared and stored in developing countries. Methods We purchased 221 pharmaceutical samples belonging to different therapeutic classes both in authorized and illegal pharmacies and subjected them to European Pharmacopoeia, 7th ed. quality tests. An ultraviolet-visible spectrophotometric assay was used to determine the galenics stability under different conditions of temperature (T) and relative humidity (RH). Results Substantial percentage of samples was substandard (52%) and thus had to be considered as counterfeit. Regarding the stability tests for galenics, it was possible to determine that the tested dosage forms were stable for a period of 24 months in “standard” (T=25±2°C, RH=50±5%) conditions. In “accelerated” (T=40±2°C, RH=50±5%) conditions, samples were stable for 3 months provided that they were stored in glass containers. Stability results of samples stored in “accelerated” conditions were similar to those obtained by performing tests on site in tropical countries and could so supply precious information on the expected stability of galenics in tropical countries. Conclusion This study gives useful information about the presence of counterfeit medicinal products in the pharmacies of many developing countries. This should serve as an alarm bell and an input for the production of galenics. We recommend setting up of galenic laboratories in developing countries around the globe.File | Dimensione | Formato | |
---|---|---|---|
cmj_53_2_brusa_22522996.pdf
Accesso aperto
Tipo di file:
PDF EDITORIALE
Dimensione
437.16 kB
Formato
Adobe PDF
|
437.16 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.